Goodwill and Intangible Assets (Tables)

6 Months Ended

Dec. 31, 2018

Goodwill and Intangible Assets

Schedule of changes in the carrying amount of goodwill

	Generic
(In thousands)	Pharmaceuticals
Balance at June 30, 2018	$	339,566
Goodwill acquired		—
Impairment		(339,566)
Balance at December 31, 2018	$	—

Summary of intangible assets, net

	Weighted	Gross Carrying Amount				Accumulated Amortization				Intangible Assets, Net
	Avg. Life	December 31,		June 30,		December 31,		June 30,		December 31,		June 30,
(In thousands)	(Yrs.)	2018		2018		2018		2018		2018		2018
Definite-lived:
Cody Labs import license	15	$	—	$	581	$	—	$	(386)	$	—	$	195
KUPI product rights	15		416,154		416,154		(83,712)		(69,840)		332,442		346,314
KUPI trade name	2		2,920		2,920		(2,920)		(2,920)		—		—
KUPI other intangible assets	15		19,000		19,000		(3,928)		(3,295)		15,072		15,705
Silarx product rights	15		10,000		10,000		(2,389)		(2,056)		7,611		7,944
Other product rights	13		21,692		19,693		(3,396)		(1,875)		18,296		17,818
Total definite-lived		$	469,766	$	468,348	$	(96,345)	$	(80,372)	$	373,421	$	387,976
Indefinite-lived:
KUPI in-process research and development	—	$	18,000	$	18,000	$	—	$	—	$	18,000	$	18,000
Silarx in-process research and development	—		18,000		18,000		—		—		18,000		18,000
Other product rights	—		449		449		—		—		449		449
Total indefinite-lived			36,449		36,449		—		—		36,449		36,449
Total intangible assets, net		$	506,215	$	504,797	$	(96,345)	$	(80,372)	$	409,870	$	424,425

Summary of future annual amortization expense

(In thousands)
Fiscal Year Ending June 30,	Annual Amortization Expense
2019	$	15,224
2020		30,443
2021		30,443
2022		30,443
2023		30,443
Thereafter		236,425
	$	373,421